Alvotech Files Routine 6-K Report

Ticker: ALVOW · Form: 6-K · Filed: Nov 17, 2025 · CIK: 1898416

Alvotech 6-K Filing Summary
FieldDetail
CompanyAlvotech (ALVOW)
Form Type6-K
Filed DateNov 17, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, 6-K, foreign-private-issuer

TL;DR

Alvotech filed a standard 6-K, no major news.

AI Summary

Alvotech filed a Form 6-K on November 17, 2025, reporting for the month of November 2025. The company, headquartered in Luxembourg, is a foreign private issuer and files annual reports under Form 20-F. This filing does not contain specific financial figures or operational updates beyond its routine reporting status.

Why It Matters

This filing indicates Alvotech is meeting its regulatory reporting obligations as a foreign private issuer, which is standard practice for companies listed on US exchanges.

Risk Assessment

Risk Level: low — This is a routine filing that does not contain new material information or financial disclosures.

Key Players & Entities

  • Alvotech (company) — Filer of the 6-K report
  • 001-41421 (company) — SEC File Number for Alvotech
  • 20251117 (date) — Filing date of the 6-K
  • November 2025 (date) — Reporting period for the 6-K
  • Luxembourg (location) — Company headquarters

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the company has made or is required to make public pursuant to the laws of its home country, or that it has filed or will file with a stock exchange.

What is Alvotech's primary business?

Alvotech is in the business of biological products, specifically excluding diagnostic substances, as indicated by its SIC code 2836.

When was Alvotech's former company name changed?

The former company name, Alvotech Lux Holdings S.A.S., was changed on December 9, 2021.

Does Alvotech file annual reports under Form 20-F or 40-F?

Alvotech indicates it files annual reports under cover of Form 20-F.

Where is Alvotech's principal executive office located?

Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.

Filing Stats: 335 words · 1 min read · ~1 pages · Grade level 12 · Accepted 2025-11-17 07:04:27

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alvotech (Registrant) Date: November 13, 2025 /s/ Tanya Zharov Tanya Zharov General Counsel

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.